The Medial Preoptic Area (MPOA) is a critical hypothalamic region located in the preoptic area of the anterior hypothalamus. This region plays essential roles in thermoregulation, sleep-wake regulation, sexual behavior, maternal behavior, and autonomic function. The MPOA is increasingly recognized for its involvement in neurodegenerative diseases, particularly those affecting autonomic function and sleep regulation. [1]
The medial preoptic area occupies the medial portion of the preoptic region, situated between the optic chiasm and the anterior commissure. This region contains a heterogeneous population of neurons, primarily GABAergic, that integrate sensory, endocrine, and circadian information to regulate homeostasis. [2]
The MPOA contains diverse neuronal populations: [3]
The MPOA serves as the primary thermoregulatory center: [4]
The MPOA is a critical sleep-promoting region: [5]
The MPOA regulates sexual and maternal behaviors: [6]
The MPOA integrates autonomic functions: [7]
MPOA involvement in AD relates to: [8]
MPOA pathology in PD contributes to:
MPOA involvement in MSA:
MPOA involvement in ALS:
Targeting hypothalamic regions including MPOA may benefit:
The study of Medial Preoptic Area Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nakamura et al. Medial preoptic area and thermoregulation (2019). 2019. ↩︎
Saper et al. hypothalamic regulation of sleep (2010). 2010. ↩︎
Kelley et al. Medial preoptic area and maternal behavior (2013). 2013. ↩︎
Tsunematsu et al. Medial preoptic area neurons in sleep-wake regulation (2014). 2014. ↩︎
Rothhaas et al. Medial preoptic area and autonomic function (2016). 2016. ↩︎
Zhang et al. Thermoregulatory circuits in the hypothalamus (2020). 2020. ↩︎
Braak et al. Staging of hypothalamic pathology in neurodegenerative disease (2003). 2003. ↩︎
Jellinger et al. hypothalamic changes in MSA (2000). 2000. ↩︎